Skip to main content
. 2020 Oct 30;22(Suppl 1):iv1–iv96. doi: 10.1093/neuonc/noaa200

Table 12.

Five-Year Total, Annual Average Totala, and Average Annual Age-Adjusted Incidence Ratesb with 95% Confidence Intervals for Brain and Other Central Nervous System Tumors by Major Histology Grouping, Histology, and Racec, CBTRUS Statistical Report: U.S. Cancer Statistics – U.S. Cancer Statistics - NPCR and SEER, 2013-2017

Histology White Black American Indian/Alaska Native Asian/Pacific Islander
5 year total Annual average Rate 95% CI 5 year total Annual average Rate 95% CI 5 year total Annual average Rate 95% CI 5 year total Annual average Rate 95% CI
Tumors of Neuroepithelial Tissue 99,024 19,805 7.10 7.06-7.15 8,501 1,700 3.92 3.84-4.01 632 126 3.10 2.85-3.37 2,561 512 2.69 2.59-2.80
Pilocytic Astrocytoma 4,195 839 0.38 0.37-0.39 621 124 0.26 0.24-0.29 35 7 0.14 0.10-0.19 120 24 0.13 0.11-0.16
Diffuse Astrocytoma 6,406 1,281 0.49 0.48-0.50 592 118 0.27 0.25-0.29 59 12 0.28 0.21-0.36 191 38 0.20 0.17-0.23
Anaplastic Astrocytoma 6,300 1,260 0.47 0.45-0.48 466 93 0.22 0.20-0.24 38 8 0.18 0.12-0.25 189 38 0.19 0.16-0.22
Unique Astrocytoma Variants 896 179 0.07 0.07-0.08 142 28 0.06 0.05-0.07 -- -- -- -- 47 9 0.05 0.04-0.07
Malignant 639 128 0.05 0.05-0.06 76 15 0.03 0.03-0.04 -- -- -- -- 31 6 0.03 0.02-0.04
Non-Malignant 257 51 0.02 0.02-0.03 66 13 0.03 0.02-0.04 -- -- -- -- 16 3 0.02 0.01-0.03
Glioblastoma 54,211 10,842 3.51 3.48-3.54 3,683 737 1.77 1.71-1.83 264 53 1.49 1.30-1.69 1,107 221 1.18 1.11-1.25
Oligodendroglioma 3,242 648 0.26 0.25-0.27 244 49 0.12 0.10-0.13 29 6 0.13 0.09-0.19 85 17 0.08 0.07-0.10
Anaplastic Oligodendroglioma 1,627 325 0.12 0.12-0.13 102 20 0.05 0.04-0.06 -- -- -- -- 67 13 0.07 0.05-0.09
Oligoastrocytic Tumors 1,398 280 0.11 0.11-0.12 85 17 0.04 0.03-0.05 -- -- -- -- 43 9 0.04 0.03-0.06
Ependymal Tumors 5,837 1,167 0.46 0.45-0.47 576 115 0.26 0.24-0.28 41 8 0.18 0.13-0.25 179 36 0.18 0.16-0.21
Malignant 3,316 663 0.26 0.25-0.27 381 76 0.17 0.15-0.19 18 4 0.08 0.05-0.12 129 26 0.13 0.11-0.16
Non-Malignant 2,521 504 0.19 0.19-0.20 195 39 0.09 0.08-0.10 23 5 0.11 0.07-0.16 50 10 0.05 0.04-0.07
Glioma Malignant, NOS 6,703 1,341 0.53 0.52-0.54 881 176 0.40 0.37-0.43 55 11 0.26 0.19-0.34 205 41 0.22 0.19-0.25
Choroid Plexus Tumors 697 139 0.06 0.05-0.06 72 14 0.03 0.02-0.04 -- -- -- -- -- -- -- --
Malignant 99 20 0.01 0.01-0.01 18 4 0.01 0.00-0.01 -- -- -- -- -- -- -- --
Non-Malignant 598 120 0.05 0.05-0.05 54 11 0.02 0.02-0.03 -- -- -- -- -- -- -- --
Other Neuroepithelial Tumors 81 16 0.01 0.01-0.01 -- -- -- -- -- -- -- -- -- -- -- --
Malignant 48 10 0.00 0.00-0.01 -- -- -- -- -- -- -- -- -- -- -- --
Non-Malignant 33 7 0.00 0.00-0.00 -- -- -- -- -- -- -- -- -- -- -- --
Neuronal and Mixed Neuronal Glial Tumors 4,064 813 0.34 0.33-0.35 514 103 0.23 0.21-0.25 35 7 0.14 0.10-0.20 158 32 0.16 0.14-0.19
Malignant 806 161 0.06 0.06-0.06 70 14 0.03 0.03-0.04 -- -- -- -- 36 7 0.04 0.03-0.05
Non-Malignant 3,258 652 0.28 0.27-0.29 444 89 0.19 0.17-0.21 28 6 0.11 0.07-0.16 122 24 0.13 0.10-0.15
Tumors of the Pineal Region 622 124 0.05 0.05-0.05 111 22 0.05 0.04-0.06 -- -- -- -- 22 4 0.02 0.01-0.04
Malignant 331 66 0.03 0.02-0.03 79 16 0.03 0.03-0.04 -- -- -- -- -- -- -- --
Non-Malignant 291 58 0.02 0.02-0.03 32 6 0.01 0.01-0.02 -- -- -- -- -- -- -- --
Embryonal Tumors 2,745 549 0.25 0.24-0.26 399 80 0.17 0.15-0.18 35 7 0.14 0.10-0.19 130 26 0.15 0.12-0.17
Tumors of Cranial and Spinal Nerves 30,265 6,053 2.13 2.11-2.16 2,241 448 1.05 1.01-1.10 227 45 1.11 0.97-1.27 1,662 332 1.66 1.58-1.75
Nerve Sheath Tumors 30,231 6,046 2.13 2.11-2.16 2,238 448 1.05 1.00-1.09 226 45 1.11 0.96-1.27 1,661 332 1.66 1.58-1.75
Malignant 171 34 0.01 0.01-0.01 27 5 0.01 0.01-0.02 -- -- -- -- -- -- -- --
Non-Malignant 30,060 6,012 2.12 2.09-2.14 2,211 442 1.04 0.99-1.08 225 45 1.10 0.96-1.26 1,647 329 1.65 1.57-1.73
Other Tumors of Cranial and Spinal Nerves 34 7 0.00 0.00-0.00 -- -- -- -- -- -- -- -- -- -- -- --
Tumors of Meninges 132,895 26,579 8.90 8.85-8.95 20,560 4,112 10.44 10.29-10.59 964 193 5.70 5.32-6.09 5,871 1,174 6.49 6.33-6.67
Meningioma 129,114 25,823 8.61 8.56-8.66 20,081 4,016 10.22 10.08-10.37 939 188 5.59 5.22-5.98 5,709 1,142 6.33 6.16-6.50
Malignant 1,368 274 0.09 0.09-0.10 261 52 0.13 0.12-0.15 -- -- -- -- 82 16 0.09 0.07-0.11
Non-Malignant 127,746 25,549 8.52 8.47-8.57 19,820 3,964 10.09 9.95-10.24 -- -- -- -- 5,627 1,125 6.24 6.07-6.41
Mesenchymal Tumors 1,216 243 0.09 0.09-0.10 144 29 0.07 0.06-0.08 -- -- -- -- 60 12 0.06 0.05-0.08
Primary Melanocytic Lesions 99 20 0.01 0.01-0.01 -- -- -- -- -- -- -- -- -- -- -- --
Other Neoplasms Related to the Meninges 2,466 493 0.19 0.18-0.19 330 66 0.15 0.13-0.17 19 4 0.08 0.05-0.13 100 20 0.10 0.08-0.12
Lymphoma and Hematopoietic Neoplasms 6,854 1,371 0.45 0.44-0.46 653 131 0.32 0.29-0.34 51 10 0.29 0.21-0.39 417 83 0.45 0.41-0.50
Lymphoma 6,678 1,336 0.44 0.43-0.45 619 124 0.30 0.28-0.33 48 10 0.28 0.20-0.37 405 81 0.44 0.39-0.48
Other Hematopoietic Neoplasms 176 35 0.01 0.01-0.02 34 7 0.02 0.01-0.02 -- -- -- -- -- -- -- --
Germ Cell Tumors and Cysts 1,238 248 0.11 0.10-0.11 167 33 0.07 0.06-0.08 -- -- -- -- 118 24 0.13 0.11-0.15
Germ Cell Tumors, Cysts and Heterotopias 1,238 248 0.11 0.10-0.11 167 33 0.07 0.06-0.08 -- -- -- -- 118 24 0.13 0.11-0.15
Malignant 840 168 0.08 0.07-0.08 113 23 0.05 0.04-0.06 -- -- -- -- 100 20 0.11 0.09-0.13
Non-Malignant 398 80 0.03 0.03-0.04 54 11 0.02 0.02-0.03 -- -- -- -- 18 4 0.02 0.01-0.03
Tumors of Sellar Region 52,691 10,538 3.97 3.93-4.00 14,603 2,921 7.00 6.88-7.11 629 126 3.10 2.85-3.36 2,913 583 2.96 2.85-3.07
Tumors of the Pituitary 50,437 10,087 3.79 3.76-3.83 13,964 2,793 6.70 6.59-6.82 603 121 2.97 2.73-3.23 2,784 557 2.82 2.72-2.93
Malignant 102 20 0.01 0.01-0.01 28 6 0.01 0.01-0.02 -- -- -- -- -- -- -- --
Non-Malignant 50,335 10,067 3.78 3.75-3.82 13,936 2,787 6.69 6.57-6.80 600 120 2.96 2.72-3.22 2,781 556 2.82 2.71-2.93
Craniopharyngioma 2,254 451 0.18 0.17-0.18 639 128 0.29 0.27-0.32 26 5 0.12 0.08-0.19 129 26 0.14 0.11-0.16
Unclassified Tumors 16,694 3,339 1.17 1.16-1.19 2,151 430 1.09 1.04-1.14 158 32 0.89 0.75-1.05 576 115 0.65 0.60-0.71
Hemangioma 4,739 948 0.36 0.35-0.37 562 112 0.27 0.24-0.29 61 12 0.30 0.23-0.39 216 43 0.22 0.19-0.26
Neoplasm Unspecified 11,823 2,365 0.81 0.79-0.82 1,547 309 0.80 0.76-0.84 96 19 0.58 0.46-0.72 349 70 0.41 0.37-0.46
Malignant 5,697 1,139 0.37 0.36-0.38 568 114 0.31 0.28-0.33 47 9 0.29 0.21-0.39 159 32 0.20 0.17-0.23
Non-Malignant 6,126 1,225 0.43 0.42-0.45 979 196 0.49 0.46-0.53 49 10 0.29 0.21-0.39 190 38 0.22 0.19-0.25
All Other 132 26 0.01 0.01-0.01 42 8 0.02 0.01-0.03 -- -- -- -- -- -- -- --
TOTALd 339,661 67,932 23.83 23.75-23.91 48,876 9,775 23.88 23.67-24.10 2,670 534 14.23 13.67-14.82 14,118 2,824 15.04 14.78-15.29
Malignant 107,737 21,547 7.58 7.54-7.63 9,432 1,886 4.44 4.34-4.53 692 138 3.54 3.26-3.83 3,169 634 3.38 3.27-3.51
Non-Malignant 231,924 46,385 16.25 16.18-16.32 39,444 7,889 19.45 19.25-19.65 1,978 396 10.69 10.20-11.21 10,949 2,190 11.65 11.43-11.88

a. Annual average cases are calculated by dividing the five- year total by five.

b. Rates are per 100,000 and are age-adjusted to the 2000 US standard population.

c. Individuals with unknown race were excluded (N = 10,086).

d. Refers to all brain tumors including histologies not presented in this table.

- Counts and rates are not presented when fewer than 20 cases were reported for the specific category. The suppressed cases are included in the counts and rates for totals.

Abbreviations: CBTRUS, Central Brain Tumor Registry of the United States; NPCR, National Program of Cancer Registries; SEER, Surveillance, Epidemiology, and End Results Program; CI, confidence interval; NOS, not otherwise specified